$SBRA
Sabra Health Care REIT, Inc.

2021 Q2 Form 10-Q Financial Statement

#000149229821000039 Filed on August 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $152.9M $153.9M
YoY Change -0.64% -29.84%
Cost Of Revenue $28.50M $26.30M
YoY Change 8.37% 8.68%
Gross Profit $123.9M $127.6M
YoY Change -2.88% -0.47%
Gross Profit Margin 81.04% 82.9%
Selling, General & Admin $8.402M $8.500M
YoY Change -1.15% 3.66%
% of Gross Profit 6.78% 6.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $44.49M $44.20M
YoY Change 0.65% -10.66%
% of Gross Profit 35.9% 34.64%
Operating Expenses $57.89M $58.00M
YoY Change -0.18% -9.23%
Operating Profit $66.04M $69.60M
YoY Change -5.12% 8.24%
Interest Expense -$194.1M -$35.10M
YoY Change 452.87% -5.65%
% of Operating Profit -293.86% -50.43%
Other Income/Expense, Net -$3.830M -$128.0K
YoY Change 2892.19% -98.26%
Pretax Income $37.74M $42.19M
YoY Change -10.56% -52.15%
Income Tax $522.0K $433.0K
% Of Pretax Income 1.38% 1.03%
Net Earnings -$132.6M $29.62M
YoY Change -547.53% -64.6%
Net Earnings / Revenue -86.69% 19.25%
Basic Earnings Per Share -$0.61 $0.14
Diluted Earnings Per Share -$0.61 $0.14
COMMON SHARES
Basic Shares Outstanding 216.3M shares 205.6M shares
Diluted Shares Outstanding 216.3M shares 206.2M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $69.35M $28.30M
YoY Change 145.04% -40.55%
Cash & Equivalents $69.35M $28.25M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $249.3M $183.4M
YoY Change 35.91% 10.48%
LONG-TERM ASSETS
Property, Plant & Equipment $5.269B $5.359B
YoY Change -1.66% -0.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $114.0M $295.3M
YoY Change -61.4% -10.04%
Other Assets $4.588M $8.600M
YoY Change -46.65% -13.13%
Total Long-Term Assets $5.573B $5.840B
YoY Change -4.58% -1.96%
TOTAL ASSETS
Total Short-Term Assets $249.3M $183.4M
Total Long-Term Assets $5.573B $5.840B
Total Assets $5.822B $6.024B
YoY Change -3.34% -1.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $103.3M $143.3M
YoY Change -27.9% 57.82%
Accrued Expenses $16.10M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $119.4M $143.3M
YoY Change -16.67% 42.45%
LONG-TERM LIABILITIES
Long-Term Debt $2.266B $2.455B
YoY Change -7.7% -8.59%
Other Long-Term Liabilities $53.35M $63.70M
YoY Change -16.25% -16.51%
Total Long-Term Liabilities $2.320B $2.519B
YoY Change -7.91% -8.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $119.4M $143.3M
Total Long-Term Liabilities $2.320B $2.519B
Total Liabilities $2.439B $2.662B
YoY Change -8.38% -7.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $2.208M $2.056M
YoY Change 7.39% 8.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.383B $3.361B
YoY Change
Total Liabilities & Shareholders Equity $5.822B $6.024B
YoY Change -3.34% -1.63%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$132.6M $29.62M
YoY Change -547.53% -64.6%
Depreciation, Depletion And Amortization $44.49M $44.20M
YoY Change 0.65% -10.66%
Cash From Operating Activities $83.77M $93.80M
YoY Change -10.7% -31.98%
INVESTING ACTIVITIES
Capital Expenditures -$33.41M -$25.60M
YoY Change 30.5%
Acquisitions
YoY Change
Other Investing Activities -$8.401M -$3.400M
YoY Change 147.09% -101.09%
Cash From Investing Activities -$41.81M -$29.20M
YoY Change 43.18% -109.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.495M -90.50M
YoY Change -102.76% -78.69%
NET CHANGE
Cash From Operating Activities 83.77M 93.80M
Cash From Investing Activities -41.81M -29.20M
Cash From Financing Activities 2.495M -90.50M
Net Change In Cash 44.45M -25.90M
YoY Change -271.63% -204.44%
FREE CASH FLOW
Cash From Operating Activities $83.77M $93.80M
Capital Expenditures -$33.41M -$25.60M
Free Cash Flow $117.2M $119.4M
YoY Change -1.87% -13.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001492298
CY2021Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
CY2020Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34950
dei Entity Registrant Name
EntityRegistrantName
SABRA HEALTH CARE REIT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2560479
dei Entity Address Address Line1
EntityAddressAddressLine1
18500 Von Karman Avenue, Suite 550
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
393-8248
dei Security12b Title
Security12bTitle
Common stock, $.01 par value
dei Trading Symbol
TradingSymbol
SBRA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
220824104 shares
CY2021Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
763830000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
681657000 USD
CY2021Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5269447000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5285038000 USD
CY2021Q2 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
105228000 USD
CY2020Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
102839000 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
113962000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
288761000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69347000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59076000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4588000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6447000 USD
CY2021Q2 sbra Finite Lived Intangible Assets Leases Net
FiniteLivedIntangibleAssetsLeasesNet
79654000 USD
CY2020Q4 sbra Finite Lived Intangible Assets Leases Net
FiniteLivedIntangibleAssetsLeasesNet
82796000 USD
CY2021Q2 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
179915000 USD
CY2020Q4 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
160646000 USD
CY2021Q2 us-gaap Assets
Assets
5822141000 USD
CY2020Q4 us-gaap Assets
Assets
5985603000 USD
CY2021Q2 us-gaap Secured Debt
SecuredDebt
78094000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
79065000 USD
CY2021Q2 us-gaap Loans Payable To Bank
LoansPayableToBank
939692000 USD
CY2020Q4 us-gaap Loans Payable To Bank
LoansPayableToBank
1044916000 USD
CY2021Q2 us-gaap Unsecured Debt
UnsecuredDebt
1248525000 USD
CY2020Q4 us-gaap Unsecured Debt
UnsecuredDebt
1248393000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
119419000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
146276000 USD
CY2021Q2 us-gaap Below Market Lease Net
BelowMarketLeaseNet
53348000 USD
CY2020Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
57725000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
2439078000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2576375000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
220824104 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
220824104 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
210560815 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
210560815 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
2208000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2106000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4341533000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4163228000 USD
CY2021Q2 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
944504000 USD
CY2020Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
716195000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16174000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39911000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3383063000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3409228000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5822141000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5985603000 USD
CY2021Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
110783000 USD
CY2020Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
112727000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
224166000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
219239000 USD
CY2021Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
3031000 USD
CY2020Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
2606000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5972000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5457000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39118000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38584000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
75159000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78567000 USD
CY2021Q2 us-gaap Revenues
Revenues
152932000 USD
CY2020Q2 us-gaap Revenues
Revenues
153917000 USD
us-gaap Revenues
Revenues
305297000 USD
us-gaap Revenues
Revenues
303263000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44491000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44202000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88866000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88370000 USD
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
24270000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
25292000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
48713000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
50996000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8811000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8673000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17749000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17434000 USD
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-109000 USD
CY2020Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
129000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1916000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
796000 USD
CY2021Q2 sbra Operating And Interest Expense
OperatingAndInterestExpense
111364000 USD
CY2020Q2 sbra Operating And Interest Expense
OperatingAndInterestExpense
111597000 USD
sbra Operating And Interest Expense
OperatingAndInterestExpense
225225000 USD
sbra Operating And Interest Expense
OperatingAndInterestExpense
223059000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-54000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-392000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-847000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-392000 USD
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-24000 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-66000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
109000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2193000 USD
CY2021Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-3752000 USD
CY2020Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
330000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-2439000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
113000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3830000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-128000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3177000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1914000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37738000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
42192000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
76895000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
82118000 USD
CY2021Q2 sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-169789000 USD
CY2020Q2 sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-12136000 USD
sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-174799000 USD
sbra Income Loss From Equity Method Investments And Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment
-15803000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
522000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
433000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1222000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1475000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-132573000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
29623000 USD
us-gaap Net Income Loss
NetIncomeLoss
-99126000 USD
us-gaap Net Income Loss
NetIncomeLoss
64840000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216264207 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205593653 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
213870329 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205493829 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
216264207 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206219162 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213870329 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206194282 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-132573000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
29623000 USD
us-gaap Net Income Loss
NetIncomeLoss
-99126000 USD
us-gaap Net Income Loss
NetIncomeLoss
64840000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-218000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-534000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-469000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1173000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-9583000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3734000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
24206000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-44426000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9801000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4268000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23737000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43253000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-142374000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25355000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75389000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21587000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3395213000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
29623000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4268000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2969000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-13000 USD
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2020Q2 us-gaap Dividends Common Stock
DividendsCommonStock
62273000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3361251000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3503404000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-132573000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9801000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2857000 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84591000 USD
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q2 us-gaap Dividends Common Stock
DividendsCommonStock
65415000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3383063000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3488460000 USD
us-gaap Net Income Loss
NetIncomeLoss
64840000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43253000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5957000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
705000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
us-gaap Dividends Common Stock
DividendsCommonStock
155291000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3361251000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3409228000 USD
us-gaap Net Income Loss
NetIncomeLoss
-99126000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23737000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5692000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
172715000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
us-gaap Dividends Common Stock
DividendsCommonStock
129183000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3383063000 USD
us-gaap Net Income Loss
NetIncomeLoss
-99126000 USD
us-gaap Net Income Loss
NetIncomeLoss
64840000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88866000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
88370000 USD
sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-10627000 USD
sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-6567000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
914000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1135000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3645000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4458000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4559000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4735000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-847000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-392000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1916000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
796000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-2439000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
113000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
164126000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-10673000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-15803000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
7083000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2361000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1377000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11777000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8680000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
152266000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
168605000 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
62107000 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
92945000 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
1651000 USD
sbra Payments For Preferred Equity Investments
PaymentsForPreferredEquityInvestments
3394000 USD
sbra Payments For Preferred Equity Investments
PaymentsForPreferredEquityInvestments
0 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
21736000 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
19867000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1135000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1610000 USD
sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-513000 USD
sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-3064000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8381000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
9516000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1305000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77208000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98968000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
73000000 USD
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
110000000 USD
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
0 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1446000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1669000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
722000 USD
sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
172698000 USD
sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
1860000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
128050000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
154068000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-66805000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-81599000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8253000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11962000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-376000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65523000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49143000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73935000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36805000 USD
us-gaap Interest Paid Net
InterestPaidNet
45658000 USD
us-gaap Interest Paid Net
InterestPaidNet
47667000 USD
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
20731000 USD
us-gaap Transfer Mortgage Payable
TransferMortgagePayable
0 USD
us-gaap Transfer Mortgage Payable
TransferMortgagePayable
14219000 USD
sbra Proceeds From Government Assistance
ProceedsFromGovernmentAssistance
500000 USD
CY2021Q2 sbra Proceeds From Government Assistance
ProceedsFromGovernmentAssistance
500000 USD
CY2021Q2 sbra Real Estate Investments Joint Ventures Number
RealEstateInvestmentsJointVenturesNumber
0 investment
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
CY2021Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6033277000 USD
CY2021Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
763830000 USD
CY2021Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5269447000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5966695000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
681657000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5285038000 USD
CY2021Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5178684000 USD
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5120598000 USD
CY2021Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
255018000 USD
CY2020Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
249034000 USD
CY2021Q2 us-gaap Land Improvements
LandImprovements
2940000 USD
CY2020Q4 us-gaap Land Improvements
LandImprovements
2220000 USD
CY2021Q2 us-gaap Land
Land
596635000 USD
CY2020Q4 us-gaap Land
Land
594843000 USD
CY2021Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6033277000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5966695000 USD
CY2021Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
763830000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
681657000 USD
CY2021Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5269447000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5285038000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2021Q2 us-gaap Security Deposit Liability
SecurityDepositLiability
11300000 USD
CY2020Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
17500000 USD
CY2021Q2 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
92000000 USD
CY2020Q4 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
85000000 USD
CY2021Q2 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
16800000 USD
CY2020Q4 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
16900000 USD
CY2021Q2 us-gaap Variable Lease Income
VariableLeaseIncome
4800000 USD
us-gaap Variable Lease Income
VariableLeaseIncome
9600000 USD
CY2020Q2 us-gaap Variable Lease Income
VariableLeaseIncome
5500000 USD
us-gaap Variable Lease Income
VariableLeaseIncome
10700000 USD
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
217032000 USD
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
417624000 USD
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
407733000 USD
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
408704000 USD
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
400077000 USD
CY2021Q2 sbra Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
1576771000 USD
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
3427941000 USD
CY2021Q2 sbra Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
18 loan
CY2021Q2 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
64186000 USD
CY2021Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
60200000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
61357000 USD
CY2021Q2 sbra Financing Receivable Fixed Interest Rate
FinancingReceivableFixedInterestRate
0.078
CY2021Q2 sbra Financing Receivable Effective Interest Rate
FinancingReceivableEffectiveInterestRate
0.079
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4269000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2458000 USD
CY2021Q2 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
64186000 USD
CY2021Q2 us-gaap Notes Receivable Net
NotesReceivableNet
55931000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
58899000 USD
CY2021Q2 sbra Preferred Equity Investments Number
PreferredEquityInvestmentsNumber
7 preferredEquityInvestment
CY2021Q2 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
49064000 USD
CY2021Q2 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
49297000 USD
CY2020Q4 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
43940000 USD
CY2021Q2 sbra Preferred Equity Investment Weighted Average Contractual Rate
PreferredEquityInvestmentWeightedAverageContractualRate
0.112
CY2021Q2 sbra Preferred Equity Investment Weighted Average Effective Rate
PreferredEquityInvestmentWeightedAverageEffectiveRate
0.112
CY2021Q2 sbra Numberof Investments
NumberofInvestments
25 investment
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2200000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4500000 USD
CY2021Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
16100000 USD
CY2021Q2 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
113250000 USD
CY2021Q2 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
105228000 USD
CY2020Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
102839000 USD
CY2021Q2 sbra Investments Weighted Average Contractual Rate
InvestmentsWeightedAverageContractualRate
0.093
CY2021Q2 sbra Investments Weighted Average Effective Rate
InvestmentsWeightedAverageEffectiveRate
0.094
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-100000 USD
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1800000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
100000 USD
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
800000 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4300000 USD
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
24300000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
48700000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
25300000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
51000000.0 USD
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1700000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3600000 USD
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2275037000 USD
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-5834000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
16100000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
17420000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2412000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
347478000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
903382000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2615000 USD
CY2021Q2 sbra Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1001730000 USD
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
14560000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
2266311000 USD
CY2021Q2 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-15039000 USD
CY2020Q2 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-11194000 USD
sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
13848000 USD
sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-39659000 USD
CY2021Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
21636000 USD
CY2021Q2 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2021Q2 us-gaap Derivative Assets
DerivativeAssets
21636000 USD
CY2021Q2 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
8273000 USD
CY2021Q2 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
7420000 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2021Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
13363000 USD
CY2021Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
23766000 USD
CY2021Q2 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2021Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
23766000 USD
CY2021Q2 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
8273000 USD
CY2021Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2021Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
15493000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
12802000 USD
CY2020Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
12802000 USD
CY2020Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
7420000 USD
CY2020Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
5382000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
37018000 USD
CY2020Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
37018000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
29598000 USD
CY2021Q2 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
64186000 USD
CY2020Q4 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
65320000 USD
CY2021Q2 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
49064000 USD
CY2020Q4 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
43724000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1900000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
900000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-132573000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29623000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216264207 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205593653 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-99126000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64840000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
213870329 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205493829 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
625509 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
700453 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
216264207 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206219162 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213870329 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206194282 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31

Files In Submission

Name View Source Status
0001492298-21-000039-index-headers.html Edgar Link pending
0001492298-21-000039-index.html Edgar Link pending
0001492298-21-000039.txt Edgar Link pending
0001492298-21-000039-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
sbra-20210630.htm Edgar Link pending
sbra-20210630.xsd Edgar Link pending
sbra-20210630_cal.xml Edgar Link unprocessable
sbra-20210630_def.xml Edgar Link unprocessable
sbra-20210630_htm.xml Edgar Link completed
sbra-20210630_lab.xml Edgar Link unprocessable
sbra-20210630_pre.xml Edgar Link unprocessable
sbraex3112021q2.htm Edgar Link pending
sbraex3122021q2.htm Edgar Link pending
sbraex3212021q2.htm Edgar Link pending
sbraex3222021q2.htm Edgar Link pending
Show.js Edgar Link pending